Follow Valdig

  • Follow
  • Follow

Member Zone

  • Home
  • What are vascular liver diseases
  • Who we are
  • Research Projects
    • Projects
    • Rules of publication
  • Become member
  • News-Forum
    • News
    • Forum
  • Education
    • Conference Ascona
    • Portal vein thrombosis meeting Version on June 2, 2022

Reply To: Prophylaxis of SOS in patient with vascular liver disease

Home › Forums › Valdig.eu website › Prophylaxis of SOS in patient with vascular liver disease › Reply To: Prophylaxis of SOS in patient with vascular liver disease

7 May 2021 at 9h21 #2757
Pierre-Emmanuel Rautou
Keymaster

Dear Dhiraj,
I completely share what has been said: scarce data but in this specific setting Defibrotide on top of UDCA seems reasonable.
Best wishes
Pierre-Emmanuel

Latest news

  • VALDIG-EASL-ERN Webinar 14th June 2022 – 17h CEST
  • Webinar chaired by Andrea Mancuso on portal vein thrombosis in cirrhosis
  • VALDIG book is now available
  • SARS-CoV2 pandemic: booster (third) vaccination
  • Virtual VALDIG GA 2021

Latest comments

No comments to show.

Contact

Prof. Pierre-Emmanuel RAUTOU
Service d’hépatologie, Hôpital Beaujon, APHP, Clichy-la-Garenne
Inserm & Université de Paris-Cité
France

Endorsed by

Member of

Login

Forgot your password?